These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10593354)

  • 61. Monoamine oxidase and catechol-O-methyltransferase inhibitors.
    Siderowf A; Kurlan R
    Med Clin North Am; 1999 Mar; 83(2):445-67. PubMed ID: 10093587
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug treatment of Parkinson's disease.
    Quinn N
    BMJ; 1995 Mar; 310(6979):575-9. PubMed ID: 7888935
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Modern therapeutic possibilities in Parkinson disease].
    Ludin HP
    Schweiz Med Wochenschr; 1999 May; 129(19):741-7. PubMed ID: 10407949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Catechol-O-methyltransferase inhibitors in Parkinson's disease.
    Harper J; Vieira B
    Lancet; 1998 Aug; 352(9127):578. PubMed ID: 9716090
    [No Abstract]   [Full Text] [Related]  

  • 65. Current advances in Parkinson's disease.
    Ball J
    Trends Neurosci; 2001 Jul; 24(7):367-9. PubMed ID: 11467283
    [No Abstract]   [Full Text] [Related]  

  • 66. Hemiparkinsonism-hemiatrophy syndrome.
    Ayromlou H; Najmi S; Arami MA
    Arch Iran Med; 2011 Mar; 14(2):152-4. PubMed ID: 21361726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug treatments of levodopa-induced dyskinesias.
    Vale S
    Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195
    [No Abstract]   [Full Text] [Related]  

  • 68. Rationale for current therapies in Parkinson's disease.
    Romrell J; Fernandez HH; Okun MS
    Expert Opin Pharmacother; 2003 Oct; 4(10):1747-61. PubMed ID: 14521485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Parkinson's disease therapy: tailoring choices for early and late disease, young and old patients.
    Jankovic J
    Clin Neuropharmacol; 2000; 23(5):252-61. PubMed ID: 11154092
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Medical treatment of Parkinson disease.
    Stacy M
    Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Recent advances in Parkinson disease].
    Litvan I
    Rev Neurol; 1999 Jul 16-31; 29(2):139-45. PubMed ID: 10528328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].
    Krivonos OV; Fedorova NV; Chigir' IP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):24-30. PubMed ID: 14870689
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The comparative effects of medical therapies for Parkinson's disease.
    Horn S; Stern MB
    Neurology; 2004 Oct; 63(7 Suppl 2):S7-12. PubMed ID: 15477585
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of Parkinson disease].
    Cardoso F
    Arq Neuropsiquiatr; 1995 Mar; 53(1):1-10. PubMed ID: 7575192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice.
    Singh A; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2002; 24(1):23-9. PubMed ID: 11980384
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treating the progressive stages of Parkinson's disease.
    Varon J; Jacobs MB
    Postgrad Med; 1991 Jul; 90(1):63-6, 69-71. PubMed ID: 1905807
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [New dopaminergic agonists].
    de Mattos JP; Mattos VM
    Arq Neuropsiquiatr; 1999 Jun; 57(2A):329-32. PubMed ID: 10412541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet.
    Lindner MD; Plone MA; Francis JM; Emerich DF
    Brain Res Bull; 1996; 39(6):367-72. PubMed ID: 9138746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The usefulness of dopaminergic drugs in traumatic brain injury].
    Orient-López F; Terre- Boliart R; Bernabeu-Guitart M; Ramón-Rona S; Pérez-Miras A
    Rev Neurol; 2002 Aug 16-31; 35(4):362-6. PubMed ID: 12235569
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Parkinson disease: managing a complex, progressive disease at all stages.
    Giroux ML
    Cleve Clin J Med; 2007 May; 74(5):313-4, 317-8, 320-2 passim. PubMed ID: 17506237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.